Antineoplastic AgentsTropaeolaceaeClinical Trials as TopicAntibodies, MonoclonalStereoisomerismMolecular StructureContrast MediaModels, MolecularBiological TherapyMagnetic Resonance SpectroscopyGuanineNeoplasmsTreatment OutcomeNucleic Acid ConformationPlant ExtractsChemical Warfare AgentsMolecular ConformationDose-Response Relationship, DrugBiological WarfareDNAGadoliniumCell Line, TumorMicrobubblesAngiogenesis InhibitorsHydrogen BondingDrug Delivery SystemsClinical Trials, Phase II as TopicImmunosuppressive AgentsImmunoglobulin GHeterocyclic Compounds, Bridged-RingPhytotherapyBase PairingPachyrhizusAnti-Inflammatory AgentsClinical Trials, Phase III as TopicDeoxyguanosineTime FactorsAlkylating AgentsMolecular Sequence DataAntiviral AgentsDrug Therapy, CombinationStructure-Activity RelationshipDrug DesignMaytansineDeoxycytosine NucleotidesGuanosineKineticsSarinDrug InteractionsMolecular Targeted TherapyDrugs, InvestigationalG-QuadruplexesChemopreventionAntibodiesAnti-Infective AgentsApoptosisHemostaticsAntineoplastic Combined Chemotherapy ProtocolsBase SequencePlatelet Aggregation InhibitorsAdministration, TopicalAntibodies, Monoclonal, HumanizedOligodeoxyribonucleotidesAntifibrinolytic AgentsIndiaDeoxyadenine NucleotidesDrug SynergismDNA DamageRandomized Controlled Trials as TopicInosineImmunologic FactorsDrug Screening Assays, AntitumorCells, CulturedEnzyme-Linked Immunosorbent Assay7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideAntifungal AgentsAdenineRabbitsCarcinogensCrystallography, X-RayDrug Evaluation, PreclinicalDisease Models, AnimalAntirheumatic AgentsThiophenesSulfolobus solfataricusCell ProliferationDNA AdductsMice, Inbred BALB CPlants, MedicinalDrug Resistance, NeoplasmDermatologic AgentsAnti-Inflammatory Agents, Non-SteroidalOrganophosphorus CompoundsCell SurvivalBinding SitesX-Ray DiffractionOrganometallic CompoundsMicrobial Sensitivity TestsEnzyme InhibitorsAntineoplastic Agents, Phytogenic